Local Analgesia in Knee- and Hipatroplastic Surgery in Patients With Rheumatic Disease: Extra- vs. Intracapsulare Position of Catheter

NCT ID: NCT01050738

Last Updated: 2010-08-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-01-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Postoperative pain is part of surgery trauma. In orthopedic surgery artroplastic replacement of knee- and hipjoints are common. Postoperative pain relieve can be complicated. A new concept for pain relieve postoperative is local infiltration analgesia (LIA). This technique implicates that a catheter is left in the surgical area and that local anestesia can be administered post surgery. The goal is no or only little pain with minimal side effects. The catheter could be placed intra- or extracapsulare. The best position is not known. Primary aim is to study if position of the catheter effects the need of other postoperative analgesia. Secondary aim is to study if the position effects patient mobility within the first two days.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rheumatoid Arthritis Orthopedic Surgery Analgesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intracapsulare position

Group Type ACTIVE_COMPARATOR

Position of catheter

Intervention Type PROCEDURE

Position of catheter for administration of local anestesia.

Extracapsulare position

Group Type ACTIVE_COMPARATOR

Position of catheter

Intervention Type PROCEDURE

Position of catheter for administration of local anestesia.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Position of catheter

Position of catheter for administration of local anestesia.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients undergoing arthroplastic surgery of knee or hip

Exclusion Criteria

* Sensitivity to local anesthetics
* Other reason not to use local anesthetics
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Spenshult Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

R&D-center Spenshult

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan Bergman, MD, PhD

Role: STUDY_CHAIR

R&D-center Spenshult

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Spenshult Hospital

Oskarström, , Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Igor Dobrydnjov, MD, PhD

Role: CONTACT

+46-352635000

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Igor Dobrydnjov, MD, PhD

Role: primary

+46-352635000

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FOUS09002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Post-op Ketamine Study
NCT03865550 UNKNOWN NA
ESPB vs iPACK+ACB in Total Knee Arthroplasty
NCT06302218 NOT_YET_RECRUITING PHASE4